These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 25684155)
1. Efficacy of dexamethasone intravitreal implant for the treatment of diabetic macular edema. Bonnin S; Dupas B; Sanharawi ME; Perol J; Erginay A; Tadayoni R; Massin P Eur J Ophthalmol; 2015; 25(5):448-53. PubMed ID: 25684155 [TBL] [Abstract][Full Text] [Related]
2. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA; BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes. Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587 [TBL] [Abstract][Full Text] [Related]
4. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification. Sze AM; Luk FO; Yip TP; Lee GK; Chan CK Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857 [TBL] [Abstract][Full Text] [Related]
5. The Efficiency of Intravitreal Dexamethasone Implants in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion. Unsal E; Eltutar K; Sultan P; Gungel H J Ocul Pharmacol Ther; 2015; 31(6):350-6. PubMed ID: 26133058 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema. Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343 [TBL] [Abstract][Full Text] [Related]
7. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema. Arıkan Yorgun M; Toklu Y; Mutlu M Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema. Esen E; Sizmaz S; Demircan N Int Ophthalmol; 2017 Feb; 37(1):1-6. PubMed ID: 26968412 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Zucchiatti I; Lattanzio R; Querques G; Querques L; Del Turco C; Cascavilla ML; Bandello F Ophthalmologica; 2012; 228(2):117-22. PubMed ID: 22310491 [TBL] [Abstract][Full Text] [Related]
10. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant. Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema. Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of single-dose dexamethasone implantation in patients with persistent diabetic macular edema. Arıkan Yorgun M; Toklu Y; Mutlu M; Uysal BS; Çakmak HB Int Ophthalmol; 2016 Aug; 36(4):531-9. PubMed ID: 26644130 [TBL] [Abstract][Full Text] [Related]
14. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity. Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825 [TBL] [Abstract][Full Text] [Related]
15. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis. Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942 [TBL] [Abstract][Full Text] [Related]
17. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group. Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF; Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477 [TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients. Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema. Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940 [TBL] [Abstract][Full Text] [Related]
20. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study. Rosenblatt A; Udaondo P; Cunha-Vaz J; Sivaprasad S; Bandello F; Lanzetta P; Kodjikian L; Goldstein M; Habot-Wilner Z; Loewenstein A; Ophthalmology; 2020 Mar; 127(3):377-393. PubMed ID: 31932090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]